Skip to content
Navigating a New Political Landscape: View real-time updates about the impact of and Northeastern’s response to recent political changes.
Apply
Stories

mRNA HIV vaccine achieves 97 percent efficacy in George Washington School of Medicine and Health Sciences human trials

People in this story

George Washington Hatchet, January 2023

The George Washington School of Medicine and Health Sciences achieved a 97 percent success rate after conducting the first-ever human trials of the mRNA HIV vaccine over the past year, according to a release the school issued last month.

Researchers created a molecule inside the vaccine that elicits a response from bnAb precursor B cells, which eventually turn into cells that produce bnAbs – neutralizing antibodies that target the HIV virus, according to the study’s release. David Diemert, the clinical director of the GW Vaccine Research Unit, said in the release that the trials produced an efficacy rate that is more than 66 percent higher than any other HIV vaccine that has been tested on humans.

Continue reading at The George Washington Hatchet.

More Stories

A bust of Mr. Musk in Brownsville, Texas, where Mr. Musk’s company SpaceX has a launch site.

Trump Has Power, a Big Megaphone and Billions to Spend. So Does Musk.

06.06.2025
President Donald Trump speaks during a rally at Macomb Community College on April 29, 2025 at Warren, Michigan. Scott Olson/Getty Images

Gen Z Voters Are Ditching GOP for Midterms—Poll

06.06.2025

Deadly decisions? Trump cuts gut anti-crime programs as summer violence looms

06.06.25
All Stories